Daiwa Securities Group’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Daiwa Securities Group's ABMD Position: Q4 2022 in Review
Daiwa Securities Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,067 shares — an estimated $753K sold.
Daiwa Securities Group first reported a position in ABMD in Q2 2018 and held it in 18 quarters. The position peaked at $1.02M in Q1 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Daiwa Securities Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Daiwa Securities Group sold 3,067 Abiomed Inc shares in Q4 2022, an estimated $753K.
- Daiwa Securities Group first reported a position in Abiomed Inc in Q2 2018 and held it in 18 quarters.
- Daiwa Securities Group's Abiomed Inc position peaked at $1.02M in Q1 2021.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.